Restricted accessResearch articleFirst published online 2019-3
A Pilot Study Using a Multistaged Integrated Analysis of Gene Expression and Methylation to Evaluate Mechanisms for Evening Fatigue in Women Who Received Chemotherapy for Breast Cancer
Fatigue is the most common symptom associated with cancer and its treatment. Investigation of molecular mechanisms associated with fatigue may identify new therapeutic targets.
Objective:
The objective of this pilot study was to evaluate the relationships between gene expression and methylation status and evening fatigue severity in women with breast cancer who received chemotherapy.
Methods:
Latent class analysis (LCA) was used to identify evening fatigue phenotypes. In this analysis, the lowest (i.e., moderate, n = 7) and highest (i.e., very high, n = 29) fatigue-severity classes identified using LCA were analyzed via two stages. First, a total of 32,609 transcripts from whole blood were evaluated for differences in expression levels between the classes. Next, 637 methylation sites located within the putative transcription factor binding sites for those genes demonstrating differential expression were evaluated for differential methylation state between the classes.
Results:
A total of 89 transcripts in 75 unique genes were differentially expressed between the moderate (the lowest fatigue-severity class identified) and very high evening fatigue classes. In addition, 23 differentially methylated probes and three differentially methylated regions were found between the moderate and very high evening fatigue classes.
Conclusions:
Using a multistaged integrated analysis of gene expression and methylation, differential methylation was identified in the regulatory regions of genes associated with previously hypothesized mechanisms for fatigue, including inflammation, immune function, neurotransmission, circadian rhythm, skeletal muscle energy, carbohydrate metabolism, and renal function as well as core biological processes including gene transcription and the cell-cycle regulation.
AliM.Rincon-AranoH.ZhaoW.RothbartS. B.TongQ.ParkhurstS. M.…KutateladzeT. G. (2013). Molecular basis for chromatin binding and regulation of MLL5. Proceedings of the National Academy of Sciences USA, 110, 11296–11301.
2.
AmesR. S.SarauH. M.ChambersJ. K.WilletteR. N.AiyarN. V.RomanicA. M.…DouglasS. A. (1999). Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14. Nature, 401, 282–286.
3.
AmroA.Waldum-GrevboB.von der LippeN.BrekkeF. B.MiaskowskiC.OsI. (2016). Symptom clusters from dialysis to renal transplantation: A five-year longitudinal study. Journal of Pain and Symptom Management, 51, 512–519.
4.
AndersenJ. S.WilkinsonC. J.MayorT.MortensenP.NiggE. A.MannM. (2003). Proteomic characterization of the human centrosome by protein correlation profiling. Nature, 426, 570–574.
5.
ArgiropoulosB.HumphriesR. K. (2007). Hox genes in hematopoiesis and leukemogenesis. Oncogene, 26, 6766.
6.
AryeeM. J.JaffeA. E.Corrada-BravoH.Ladd-AcostaC.FeinbergA. P.HansenK. D.IrizarryR. A. (2014). Minfi: A flexible and comprehensive bioconductor package for the analysis of infinium DNA methylation microarrays. Bioinformatics, 30, 1363–1369.
7.
BarsevickA.FrostM.ZwindermanA.HallP.HalyardM.ConsortiumG. (2010). I’m so tired: Biological and genetic mechanisms of cancer-related fatigue. Quality of Life Research, 19, 1419–1427.
8.
BergerA. M.MooneyK.Alvarez-PerezA.BreitbartW. S.CarpenterK. M.CellaD.…SmithC. (2015). Cancer-related fatigue, version 2.2015. Journal of National Comprehensive Cancer Networks, 13, 1012–1039.
9.
BerthonA. S.SzarekE.StratakisC. A. (2015). PRKACA: The catalytic subunit of protein kinase A and adrenocortical tumors. Frontiers in Cellular and Developmental Biology, 3, 26.
10.
BezbradicaJ. S.MedzhitovR. (2009). Integration of cytokine and heterologous receptor signaling pathways. Nature Immunology, 10, 333–339.
11.
BowerJ. E. (2014). Cancer-related fatigue—Mechanisms, risk factors, and treatments. Nature Reviews Clinical Oncology, 11, 597–609.
12.
BowerJ. E.GanzP. A. (2015). Symptoms: Fatigue and cognitive dysfunction. Advances in Experimental Medicine and Biology, 862, 53–75.
13.
BrameierM.HerwigA.ReinhardtR.WalterL.GruberJ. (2011). Human box C/D snoRNAs with miRNA like functions: Expanding the range of regulatory RNAs. Nucleic Acids Research, 39, 675–686.
14.
BuescherJ. M.DriggersE. M. (2016). Integration of omics: More than the sum of its parts. Cancer & Metabolism, 4, 4.
15.
ColeS. W. (2013). Nervous system regulation of the cancer genome. Brain, Behavior, and Immunity, 30, S10–S18.
16.
ColeS. W.HawkleyL. C.ArevaloJ. M.CacioppoJ. T. (2011). Transcript origin analysis identifies antigen-presenting cells as primary targets of socially regulated gene expression in leukocytes. Proceedings of the National Academy of Sciences USA, 108, 3080–3085.
17.
DanielsenJ. M.SylvestersenK. B.Bekker-JensenS.SzklarczykD.PoulsenJ. W.HornH.…NielsenM. L. (2011). Mass spectrometric analysis of lysine ubiquitylation reveals promiscuity at site level. Molecular and Cellular Proteomics, 10, M110.003590.
18.
DantzerR.O’ConnorJ. C.FreundG. G.JohnsonR. W.KelleyK. W. (2008). From inflammation to sickness and depression: When the immune system subjugates the brain. Nature Reviews Neuroscience, 9, 46–56.
19.
DerfussT.ParikhK.VelhinS.BraunM.MatheyE.KrumbholzM.…MeinlE. (2009). Contactin-2/TAG-1-directed autoimmunity is identified in multiple sclerosis patients and mediates gray matter pathology in animals. Proceedings of the National Academy of Sciences USA, 106, 8302–8307.
20.
Di PietroC.RapisardaA.AmicoV.BonaiutoC.ViolaA.ScaliaM.…PurrelloM. (2000). Genomic localization of the human genes TAF1A, TAF1B and TAF1C, encoding TAF(I)48, TAF(I)63 and TAF(I)110 subunits of class I general transcription initiation factor SL1. Cytogenetics and Cell Genetics, 89, 133–136.
21.
DoongS. H.DhruvaA.DunnL. B.WestC.PaulS. M.CooperB. A.…MiaskowskiC. (2015). Associations between cytokine genes and a symptom cluster of pain, fatigue, sleep disturbance, and depression in patients prior to breast cancer surgery. Biological Research for Nursing, 17, 237–247.
22.
DuS.LawrenceE. J.StrzeleckiD.RajputP.XiaS. J.GottesmanD. M.BarrF. G. (2005). Co-expression of alternatively spliced forms of PAX3, PAX7, PAX3-FKHR and PAX7-FKHR with distinct DNA binding and transactivation properties in rhabdomyosarcoma. International Journal of Cancer, 115, 85–92.
23.
EnderC.KrekA.FriedlanderM. R.BeitzingerM.WeinmannL.ChenW.…MeisterG. (2008). A human snoRNA with microRNA-like functions. Molecular Cell, 32, 519–528.
24.
EsmonC. T. (2005). The interactions between inflammation and coagulation. British Journal of Haematology, 131, 417–430.
25.
FagerbergL.HallstromB. M.OksvoldP.KampfC.DjureinovicD.OdebergJ.…UhlenM. (2014). Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Molecular and Cellular Proteomics, 13, 397–406.
26.
FalaleevaM.PagesA.MatuszekZ.HidmiS.Agranat-TamirL.KorotkovK.…StammS. (2016). Dual function of C/D box small nucleolar RNAs in rRNA modification and alternative pre-mRNA splicing. Proceedings of the National Academy of Sciences USA, 113, E1625–E1634.
27.
FinlinB. S.CrumpS. M.SatinJ.AndresD. A. (2003). Regulation of voltage-gated calcium channel activity by the Rem and Rad GTPases. Proceedings of the National Academy of Sciences USA, 100, 14469–14474.
28.
FletcherB. S.PaulS. M.DoddM. J.SchumacherK.WestC.CooperB.…MiaskowskiC. (2008). Prevalence, severity, and impact of symptoms on female family caregivers of patients at the initiation of radiation therapy for prostate cancer. Journal of Clinical Oncology, 26, 599–605.
29.
FlowersE.MiaskowskiC.ConleyY.HammerM. J.LevineJ.MastickJ.…KoberK. M. (2018). Differential expression of genes and differentially perturbed pathways associated with very high evening fatigue in oncology patients receiving chemotherapy. Supportive Care in Cancer, 26, 739–750.
30.
GleesonM.BishopN. C.StenselD. J.LindleyM. R.MastanaS. S.NimmoM. A. (2011). The anti-inflammatory effects of exercise: Mechanisms and implications for the prevention and treatment of disease. Nature Reviews Immunology, 11, 607–615.
31.
GopalakrishnanC.KamarajB.PurohitR. (2014). Mutations in microRNA binding sites of CEP genes involved in cancer. Cell Biochemistry and Biophysics, 70, 1933–1942.
32.
HarringtonA. J.YacoubianT. A.SloneS. R.CaldwellK. A.CaldwellG. A. (2012). Functional analysis of VPS41-mediated neuroprotection in Caenorhabditis elegans and mammalian models of Parkinson’s disease. Journal of Neuroscience, 32, 2142–2153.
33.
HeW. Y.ChenG. J.LaiX.WuF.TangC. S.ZhangA. H. (2016). Expression levels of urotensin II are associated with endoplasmic reticulum stress in patients with severe preeclampsia. Journal of Human Hypertension, 30, 129–135.
34.
HerrmannG.KaisS.HoffbauerJ.Shah-HosseiniK.BruggenolteN.SchoberH.…ScharP. (2007). Conserved interactions of the splicing factor Ntr1/Spp382 with proteins involved in DNA double-strand break repair and telomere metabolism. Nucleic Acids Research, 35, 2321–2332.
35.
HochbergY.BenjaminiY. (1990). More powerful procedures for multiple significance testing. Statistics in Medicine, 9, 811–818.
36.
HsiaoC. P.ReddyS. Y.ChenM. K.SaliganL. N. (2016). Genomic profile of fatigued men receiving localized radiation therapy. Biological Research for Nursing, 18, 281–289.
37.
HursitogluM.TukekT.CikrikciogluM. A.KaraO.KazanciogluR.OzkanO.…ErekA. (2012). Urotensin II levels in patients with chronic kidney disease and kidney transplants. Upsala Journal of Medical Sciences, 117, 22–27.
38.
IijimaM.KoikeH.KatsunoM.SobueG. (2011). Polymorphism of transient axonal glycoprotein-1 in chronic inflammatory demyelinating polyneuropathy. Journal of the Peripheral Nervous System, 16, 52–55.
39.
IlliJ.MiaskowskiC.CooperB.LevineJ. D.DunnL.WestC.…AouizeratB. E. (2012). Association between pro- and anti-inflammatory cytokine genes and a symptom cluster of pain, fatigue, sleep disturbance, and depression. Cytokine, 58, 437–447.
40.
IrwinM. R.ColeS. W. (2011). Reciprocal regulation of the neural and innate immune systems. Nature Reviews Immunology, 11, 625–632.
41.
JaffeA. E.MurakamiP.LeeH.LeekJ. T.FallinM. D.FeinbergA. P.IrizarryR. A. (2012). Bump hunting to identify differentially methylated regions in epigenetic epidemiology studies. International Journal of Epidemiology, 41, 200–209.
42.
JonesP. A. (1999). The DNA methylation paradox. Trends in Genetics, 15, 34–37.
43.
JonesP. A. (2012). Functions of DNA methylation: Islands, start sites, gene bodies and beyond. Nature Reviews Genetics, 13, 484–492.
44.
JoungH.EomG. H.ChoeN.LeeH. M.KoJ. H.KwonD. H.…KookH. (2014). Ret finger protein mediates Pax7-induced ubiquitination of MyoD in skeletal muscle atrophy. Cellular Signaling, 26, 2240–2248.
45.
KarnofskyD. A.AbelmannW. H.CraverL. V.BurchenalJ. H. (1948). The use of nitrogen mustards in the palliative treatment of carcinoma. Cancer, 1, 634–656.
46.
KassS. U.LandsbergerN.WolffeA. P. (1997). DNA methylation directs a time-dependent repression of transcription initiation. Current Biology, 7, 157–165.
47.
KerrK. F. (2009). Comments on the analysis of unbalanced microarray data. Bioinformatics, 25, 2035–2041.
48.
KimK. H.LeeJ.HanJ. H.MyungS. C. (2014). Beta-defensin 124 is required for efficient innate immune responses in prostate epithelial RWPE-1 cells. Korean Journal of Urology, 55, 417–425.
49.
KoberK. M.CooperB. A.PaulS. M.DunnL. B.LevineJ. D.WrightF.…MiaskowskiC. (2016). Subgroups of chemotherapy patients with distinct morning and evening fatigue trajectories. Supportive Care in Cancer, 24, 1473–1485.
50.
KoberK. M.DunnL.MastickJ.CooperB.LangfordD.MeliskoM.…MiaskowskiC. (2016). Gene expression profiling of evening fatigue in women undergoing chemotherapy for breast cancer. Biological Research for Nursing, 18, 370–385.
51.
KoberK. M.SmootB.PaulS. M.CooperB. A.LevineJ. D.MiaskowskiC. (2016). Polymorphisms in cytokine genes are associated with higher levels of fatigue and lower levels of energy in women after breast cancer surgery. Journal of Pain and Symptom Management, 52, 695–708.
52.
Landmark-HoyvikH.ReinertsenK. V.LogeJ. H.FossaS. D.Borresen-DaleA. L.DumeauxV. (2009). Alterations of gene expression in blood cells associated with chronic fatigue in breast cancer survivors. Pharmacogenomics Journal, 9, 333–340.
53.
Landmark-HoyvikH.ReinertsenK. V.LogeJ. H.KristensenV. N.DumeauxV.FossaS. D.…EdvardsenH. (2010). The genetics and epigenetics of fatigue. Physical Medicine and Rehabilitation, 2, 456–465.
54.
LanghamR. G.KellyD. J. (2013). Urotensin II and the kidney. Current Opinions in Nephrology and Hypertension, 22, 107–112.
55.
LeeK. A.HicksG.Nino-MurciaG. (1991). Validity and reliability of a scale to assess fatigue. Psychiatry Research, 36, 291–298.
56.
LiangK. C.PatilA.NakaiK. (2015). Discovery of intermediary genes between pathways using sparse regression. PLoS One, 10, e0137222.
57.
LiewC. C.MaJ.TangH. C.ZhengR.DempseyA. A. (2006). The peripheral blood transcriptome dynamically reflects system wide biology: A potential diagnostic tool. Journal of Laboratory and Clinical Medicine, 147, 126–132.
58.
MalumbresM.HarlowE.HuntT.HunterT.LahtiJ. M.ManningG.…WolgemuthD. J. (2009). Cyclin-dependent kinases: A family portrait. Nature Cell Biology, 11, 1275–1276.
59.
MartinS. T.SatoN.DharaS.ChangR.HustinxS. R.AbeT.…GogginsM. (2005). Aberrant methylation of the Human Hedgehog Interacting Protein (HHIP) gene in pancreatic neoplasms. Cancer Biology & Therapy, 4, 728–733.
60.
McCannB.MiaskowskiC.KoettersT.BaggottC.WestC.LevineJ. D.…MiaskowskiC. (2012). Associations between pro- and anti-inflammatory cytokine genes and breast pain in women prior to breast cancer surgery. Journal of Pain, 13, 425–437.
61.
McKeeA. E.MinetE.SternC.RiahiS.StilesC. D.SilverP. A. (2005). A genome-wide in situ hybridization map of RNA-binding proteins reveals anatomically restricted expression in the developing mouse brain. BMC Developmental Biology, 5, 14.
62.
McKinnellI. W.IshibashiJ.Le GrandF.PunchV. G.AddicksG. C.GreenblattJ. F.…RudnickiM. A. (2008). Pax7 activates myogenic genes by recruitment of a histone methyltransferase complex. Nature Cell Biology, 10, 77–84.
63.
MustianK. M.AlfanoC. M.HecklerC.KlecknerA. S.KlecknerI. R.LeachC. R.…MillerS. M. (2017). Comparison of pharmaceutical, psychological, and exercise treatments for cancer-related fatigue: A meta-analysis. Journal of American Medical Association Oncology, 3, 961–968.
64.
NishikuraK. (2016). A-to-I editing of coding and non-coding RNAs by ADARs. Nature Reviews Molecular Cell Biology, 17, 83–96.
65.
OhH. R.AnC. H.YooN. J.LeeS. H. (2015). Frameshift mutations of TAF1C gene, a core component for transcription by RNA polymerase I, and its regional heterogeneity in gastric and colorectal cancers. Pathology, 47, 101–104.
66.
OkudaH.KanaiA.ItoS.MatsuiH.YokoyamaA. (2015). AF4 uses the SL1 components of RNAP1 machinery to initiate MLL fusion- and AEP-dependent transcription. Nature Communications, 6, 8869.
67.
OlomuA. B.CorserW. D.StommelM.XieY.Holmes-RovnerM. (2012). Do self-report and medical record comorbidity data predict longitudinal functional capacity and quality of life health outcomes similarly?BMC Health Services Research, 12, 398.
68.
OngK. L.LamK. S.CheungB. M. (2005). Urotensin II: Its function in health and its role in disease. Cardiovascular Drugs and Therapy, 19, 65–75.
69.
PangS. Y.ChanK. H.MakW. W.KungM. H.LeeC. N.TsoiT. H.…HoS. L. (2012). Single-nucleotide polymorphism of transient axonal glycoprotein-1 and its correlation with clinical features and prognosis in chronic inflammatory demyelinating polyneuropathy. Journal of the Peripheral Nervous System, 17, 72–75.
70.
ParkS. M.ChoiE. Y.BaeM.ChoiJ. K.KimY. J. (2017). A long-range interactive DNA methylation marker panel for the promoters of HOXA9 and HOXA10 predicts survival in breast cancer patients. Clinical Epigenetics, 9, 73.
71.
PatilA. A.CaiY.SangY.BlechaF.ZhangG. (2005). Cross-species analysis of the mammalian beta-defensin gene family: Presence of syntenic gene clusters and preferential expression in the male reproductive tract. Physiological Genomics, 23, 5–17.
72.
PortelaA.EstellerM. (2010). Epigenetic modifications and human disease. Nature Biotechnology, 28, 1057–1068.
73.
PowellN. D.MaysJ. W.BaileyM. T.HankeM. L.SheridanJ. F. (2011). Immunogenic dendritic cells primed by social defeat enhance adaptive immunity to influenza A virus. Brain, Behavior, and Immunity, 25, 46–52.
74.
QuanN.BanksW. A. (2007). Brain-immune communication pathways. Brain, Behavior, and Immunity, 21, 727–735.
75.
RazinA.RiggsA. D. (1980). DNA methylation and gene function. Science, 210, 604–610.
76.
RickmanD. S.TyagiR.ZhuX. X.BobekM. P.SongS.BlaivasM.…HanashS. M. (2001). The gene for the axonal cell adhesion molecule TAX-1 is amplified and aberrantly expressed in malignant gliomas. Cancer Research, 61, 2162–2168.
77.
RitchieM. D.HolzingerE. R.LiR.PendergrassS. A.KimD. (2015). Methods of integrating data to uncover genotype-phenotype interactions. Nature Reviews Genetics, 16, 85–97.
78.
RitchieM. E.PhipsonB.WuD.HuY.LawC. W.ShiW.SmythG. K. (2015). LIMMA powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Research, 43, e47.
79.
RiuzziF.SorciG.SaghedduR.SidoniA.AlaggioR.NinfoV.DonatoR. (2014). RAGE signaling deficiency in rhabdomyosarcoma cells causes upregulation of PAX7 and uncontrolled proliferation. Journal of Cell Science, 127, 1699–1711.
80.
SaliganL. N.HsiaoC. P.WangD.WangX. M.St JohnL.KaushalA.…DionneR. A. (2013). Upregulation of alpha-synuclein during localized radiation therapy signals the association of cancer-related fatigue with the activation of inflammatory and neuroprotective pathways. Brain, Behavior, and Immunity, 27, 63–70.
81.
SaliganL. N.KimH. S. (2012). A systematic review of the association between immunogenomic markers and cancer-related fatigue. Brain, Behavior, and Immunity, 26, 830–848.
82.
SaliganL. N.OlsonK.FillerK.LarkinD.CrampF.YennurajalingamS.…MustianK. (2015). The biology of cancer-related fatigue: A review of the literature. Supportive Care in Cancer, 23, 2461–2478.
83.
SanghaO.StuckiG.LiangM. H.FosselA. H.KatzJ. N. (2003). The self-administered comorbidity questionnaire: A new method to assess comorbidity for clinical and health services research. Arthritis and Rheumatology, 49, 156–163.
84.
SarriasM. R.GronlundJ.PadillaO.MadsenJ.HolmskovU.LozanoF. (2004). The Scavenger Receptor Cysteine-Rich (SRCR) domain: An ancient and highly conserved protein module of the innate immune system. Critical Reviews in Immunology, 24, 1–37.
85.
SatohK.HataM.YokotaH. (2002). A novel member of the leucine-rich repeat superfamily induced in rat astrocytes by beta-amyloid. Biochemical and Biophysical Research Communications, 290, 756–762.
86.
SchultzM. D.HeY.WhitakerJ. W.HariharanM.MukamelE. A.LeungD.…EckerJ. R. (2015). Human body epigenome maps reveal noncanonical DNA methylation variation. Nature, 523, 212–216.
87.
SmithA. K.ConneelyK. N.PaceT. W.MisterD.FelgerJ. C.KilaruV.…TorresM. A. (2014). Epigenetic changes associated with inflammation in breast cancer patients treated with chemotherapy. Brain, Behavior, and Immunity, 38, 227–236.
88.
StephensK. E.MiaskowskiC. A.LevineJ. D.PullingerC. R.AouizeratB. E. (2013). Epigenetic regulation and measurement of epigenetic changes. Biological Research for Nursing, 15, 373–381.
89.
SteptoeA.HamerM.ChidaY. (2007). The effects of acute psychological stress on circulating inflammatory factors in humans: A review and meta-analysis. Brain, Behavior, and Immunity, 21, 901–912.
90.
StogmannE.ReinthalerE.EltawilS.El EtribiM. A.HemedaM.El NahhasN.…ZimprichA. (2013). Autosomal recessive cortical myoclonic tremor and epilepsy: Association with a mutation in the potassium channel associated gene CNTN2. Brain, 136, 1155–1160.
91.
SzklarczykD.MorrisJ. H.CookH.KuhnM.WyderS.SimonovicM.…von MeringC. (2017). The STRING database in 2017: Quality-controlled protein-protein association networks, made broadly accessible. Nucleic Acids Research, 45, D362–D368.
92.
TadaM.KanaiF.TanakaY.TateishiK.OhtaM.AsaokaY.…OmataM. (2008). Down-regulation of hedgehog-interacting protein through genetic and epigenetic alterations in human hepatocellular carcinoma. Clinical Cancer Research, 14, 3768–3776.
93.
TaniguchiH.YamamotoH.AkutsuN.NoshoK.AdachiY.ImaiK.…ShinomuraY. (2007). Transcriptional silencing of hedgehog-interacting protein by CpG hypermethylation and chromatic structure in human gastrointestinal cancer. Journal of Pathology, 213, 131–139.
94.
TomasC.NewtonJ.WatsonS. (2013). A review of hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome. International Scholarly Research Notices Neuroscience, 2013, 784520.
95.
TopalianS. L.KanekoS.GonzalesM. I.BondG. L.WardY.ManleyJ. L. (2001). Identification and functional characterization of neo-poly(A) polymerase, an RNA processing enzyme overexpressed in human tumors. Molecular Cell Biology, 21, 5614–5623.
96.
TrivediC. M.PatelR. C.PatelC. V. (2008). Differential regulation of HOXA9 expression by nuclear factor kappa B (NF-kappaB) and HOXA9. Gene, 408, 187–195.
97.
Van AllerG. S.ReynoirdN.BarbashO.HuddlestonM.LiuS.ZmoosA. F.…KrugerR. G. (2012). Smyd3 regulates cancer cell phenotypes and catalyzes histone H4 lysine 5 methylation. Epigenetics, 7, 340–343.
98.
VardabassoC.HassonD.RatnakumarK.ChungC. Y.DuarteL. F.BernsteinE. (2014). Histone variants: Emerging players in cancer biology. Cellular and Molecular Life Sciences, 71, 379–404.
99.
WagnerJ. R.BuscheS.GeB.KwanT.PastinenT.BlanchetteM. (2014). The relationship between DNA methylation, genetic and expression inter-individual variation in untransformed human fibroblasts. Genome Biology, 15, R37.
100.
WanC.BorgesonB.PhanseS.TuF.DrewK.ClarkG.…EmiliA. (2015). Panorama of ancient metazoan macromolecular complexes. Nature, 525, 339–344.
101.
WangT.YinJ.MillerA. H.XiaoC. (2017). A systematic review of the association between fatigue and genetic polymorphisms. Brain, Behavior, and Immunity, 62, 230–244.
102.
WangX. S. (2008). Pathophysiology of cancer-related fatigue. Clinical Journal of Oncology Nursing, 12, 11–20.
103.
WangX. S.WoodruffJ. F. (2015). Cancer-related and treatment-related fatigue. Gynecological Oncology, 136, 446–452.
104.
WhitfieldM. L.SherlockG.SaldanhaA. J.MurrayJ. I.BallC. A.AlexanderK. E.…BotsteinD. (2002). Identification of genes periodically expressed in the human cell cycle and their expression in tumors. Molecular Biology of the Cell, 13, 1977–2000.
105.
WoodJ. P.BunceM. W.MaroneyS. A.TracyP. B.CamireR. M.MastA. E. (2013). Tissue factor pathway inhibitor-alpha inhibits prothrombinase during the initiation of blood coagulation. Proceedings of the National Academy of Sciences USA, 110, 17838–17843.
106.
WrightF.D’Eramo MelkusG.HammerM.SchmidtB. L.KnobfM. T.PaulS. M.…MiaskowskiC. (2015a). Predictors and trajectories of morning fatigue are distinct from evening fatigue. Journal of Pain and Symptom Management, 50, 176–189.
107.
WrightF.D’Eramo MelkusG.HammerM.SchmidtB. L.KnobfM. T.PaulS. M.…MiaskowskiC. (2015b). Trajectories of evening fatigue in oncology outpatients receiving chemotherapy. Journal of Pain and Symptom Management, 50, 163–175.
108.
YanH.GuanQ.HeJ.LinY.ZhangJ.LiH.…HeF. (2017). Individualized analysis reveals CpG sites with methylation aberrations in almost all lung adenocarcinoma tissues. Journal of Translational Medicine, 15, 26.
109.
YanY.JiangY. (2016). RACK1 affects glioma cell growth and differentiation through the CNTN2-mediated RTK/Ras/MAPK pathway. International Journal of Molecular Medicine, 37, 251–257.
110.
YangX. J. (2005). Multisite protein modification and intramolecular signaling. Oncogene, 24, 1653–1662.
111.
YavuzsenT.DavisM. P.RanganathanV. K.WalshD.SiemionowV.KirkovaJ.…YueG. H. (2009). Cancer-related fatigue: Central or peripheral?Journal of Pain and Symptom Management, 38, 587–596.
112.
ZhangX.NoveraW.ZhangY.DengL. W. (2017). MLL5 (KMT2E): Structure, function, and clinical relevance. Cellular and Molecular Life Sciences, 74, 2333–2344.
113.
ZoccaliC.MallamaciF.BenedettoF. A.TripepiG.PizziniP.CutrupiS.MalatinoL. (2008). Urotensin II and cardiomyopathy in end-stage renal disease. Hypertension, 51, 326–333.
